All Stories

AstraZeneca, Memorial Sloan Kettering adopt tech firm's data capture tool for phase 3 trial

AstraZeneca and the Memorial Sloan Kettering Cancer Center have tapped digital health tech company IgniteData to provide an automated data capture tool for a phase 3 clinical trial.

Apr 1, 2025 - 20:16
 0
AstraZeneca, Memorial Sloan Kettering adopt tech firm's data capture tool for phase 3 trial
AstraZeneca and the Memorial Sloan Kettering Cancer Center have tapped digital health tech company IgniteData to provide an automated data capture tool for a phase 3 clinical trial.
Read More

Tags:

Previous Article

Lilly continues full-court press against breast cancer with women's March Madnes...

Next Article

How NORAD could be hurt by US-Canada tensions

Related Posts

Allogene’s phase 1 lymphoma data show CAR-T could ‘leapfrog’ competition: analysts

Allogene’s phase 1 lymphoma data show CAR-T could ‘leap...

Feb 14, 2025  0

FDA amplifies BD atherectomy safety alert following 4 deaths

FDA amplifies BD atherectomy safety alert following 4 d...

Feb 10, 2025  0

Health tech firm partners with UK medical recordkeeper to match patients with clinical trials

Health tech firm partners with UK medical recordkeeper ...

Feb 26, 2025  0